L-Glutamic acid,N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, monohydrate(9CI) (6745-93-3)

Identification
Name:	L-Glutamic acid,N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, monohydrate(9CI)
Synonyms:	Glutamicacid, N-[p-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-,monohydrate, L- (8CI); Methotrexate monohydrate
CAS:	6745-93-3
EINECS:	257-482-2
Molecular Formula:	C20H22 N8 O5 . H2 O
Molecular Weight:	0
InChI:	InChI=1S/C20H22N8O5.H2O/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30;/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27);1H2/t13-;/m0./s1
Molecular Structure:
Properties
Transport:	UN 1544 6.1/PG 3
Melting Point:	195 °C (dec.)(lit.)
Specification:	Safety Statements:53-22-26-36/37/39-45 53:Avoid exposure - obtain special instruction before use 22:Do not breathe dust 26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 36/37/39:Wear suitable protective clothing, gloves and eye/face protection 45:In case of accident or if you feel unwell, seek medical advice immediately (show label where possible)
Safety Data